InnFocus MicroShunt: 1-Year Outcomes

In this interview from AGS 2019, Dr. Matt Schlenker shares his experience using the InnFocus MicroShunt (Santen) to manage patients with various stages of glaucoma. The device is made with SIBS [poly(styrene-block-isobutylene-block-styrene], an ultra‐stable polymer that does not induce a foreign body reaction. In the clinical trial, approximately 85% of patients in the standalone shunt group were within the target IOP range. The benefits of using this device, explained Dr. Schlenker, include a regulated flow for minimizing hypotony and a bleb morphology that is posterior and diffuse.

Relevant Financial Disclosures: Dr. Schlenker is the recipient of an honorarium from Santen